United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
1998_register
executive
2010-09-24
article
Draft Guidance on Professional Flexible Labeling of Antimicrobial Drugs; Availability; Request for Comments
Notices
D09002ee1be0061c8
D09002ee1be006245
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is announcing the availability of a draft level 1 Guidance for Industry entitled ``Professional Flexible Labeling of Antimicrobial Drugs (#66).'' This draft guidance is intended to provide specific guidance on the development of Professional Flexible Labeling (PFL) for therapeutic veterinary prescription antimicrobial drugs. The agency is requesting comments on this draft guidance.
63 FR 3328
https://www.govinfo.gov/app/details/FR-1998-01-22/98-1417
98-1417
fr22ja98-65
4160-01-F
Docket No. 98D-0016
https://www.govinfo.gov/app/details/FR-1998-01-22/98-1417
https://www.govinfo.gov/content/pkg/FR-1998-01-22/html/98-1417.htm
https://www.govinfo.gov/content/pkg/FR-1998-01-22/pdf/98-1417.pdf
2 p.
3328
3329
63 FR 3328
Draft Guidance on Professional Flexible Labeling of Antimicrobial Drugs; Availability; Request for Comments; Federal Register Vol. 63, Issue
NOTICE
98-1417
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
1998-04-22
Docket No. 98D-0016
4160-01-F
98-1417
Notice.
The Food and Drug Administration (FDA) is announcing the availability of a draft level 1 Guidance for Industry entitled ``Professional Flexible Labeling of Antimicrobial Drugs (#66).'' This draft guidance is intended to provide specific guidance on the development of Professional Flexible Labeling (PFL) for therapeutic veterinary prescription antimicrobial drugs. The agency is requesting comments on this draft guidance.
Submit written comments by April 22, 1998. ADDRESSES: Submit written comments on the draft guidance to the Dockets Management Branch (HFA-305), Food and Drug Administration, rm. 1-23, 12420 Parklawn Dr., Rockville, MD 20857. Comments should be identified with the full title of the draft guidance and the docket number found in brackets in the heading of this document.
John D. Baker, Center for Veterinary Medicine (HFV-110), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0130. E-mail: jbaker@bangate.fda.gov.
Federal Register
Vol. 63, no. 14
Office of the Federal Register, National Archives and Records Administration
1998-01-22
continuing
daily
deposited
born digital
210 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-1998-01-22
P0b002ee180a6a03e
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr22ja98
https://www.govinfo.gov/app/details/FR-1998-01-22
https://www.govinfo.gov/content/pkg/FR-1998-01-22/pdf/FR-1998-01-22.pdf
fdlp
3247
3445
DGPO
2010-09-24
2023-05-06
FR-1998-01-22
machine generated
eng
FR
FR-1998-01-22
63
14